FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · reporting period

SYROS PHARMACEUTICALS, INC.: capex

One fact, its scope and the complete path back to the official record.

Period: 2022-01-01 – 2022-12-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/f76b4e91-2008-4b72-8595-18ae55af03e6

Reported value

$1.241M{"amount": 1241000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"}
Entity
SYROS PHARMACEUTICALS, INC.
Metric
capex
Period
2022-01-01 – 2022-12-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0000950170-23-005702 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T15:48:09.077087+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001556263/capex/2022-12-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.